Keywords: Cost analysis; Dalbavancin; Meta-analysis; Oritavancin; Systematic review;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Dalbavancina; Modelos animales; In vivo; Lipoglucopéptido; Dalbavancin; Animal models; In vivo; Lipoglycopeptide;
Keywords: Dalbavancina; Glucopéptidos; Lipoglucopéptidos; Staphylococcus aureus resistente a meticilina; Microorganismos Gram positivos; multirresistentes; Enterococos resistentes a la vancomicina; Dalbavancin; Glycopeptides; Lipoglycopeptides; Methicillin resist
Keywords: Staphylococcus aureus; MRSA; Vancomycin; Ceftaroline; Daptomycin; Dalbavancin; Telavancin; Tedizolid;
Keywords: Antimicrobial resistance; Soft tissue abscess; Intraabdominal abscess; Dalbavancin; Oritavancin; Ceftaroline fosamil; Ceftolozane-tazobactam; Ceftazidime-avibactam;
Keywords: Dalbavancin; Susceptibility testing; Surrogate marker;
Keywords: acute bacterial skin and skin structure infections; dalbavancin; oritavancin; telavancin;
Keywords: Dalbavancin; MRSA; Resistance; Multidrug-resistant; MDR; Surveillance
Keywords: ceftazidime/avibactam; ceftolozane/tazobactam; dalbavancin; oritavancin; tedizolid
Dalbavancin in the treatment of different gram-positive infections: a real-life experience
Keywords: Dalbavancin; Skin and soft-tissue infection; Gram-positive infection;
Successful treatment of Enterococcus faecalis bacteremia with dalbavancin as an outpatient in an intravenous drug user
Keywords: Dalbavancin; Intravenous drug user; Outpatient; Bacteremia; Enterococcus;
Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen
Keywords: CLABSI; Cross-resistance; Glycopeptide resistance; Lipoglycopeptide; Dalbavancin;
Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci
Keywords: Dalbavancin; Enterococcus; Biofilm;
Old and new glycopeptide antibiotics: From product to gene and back in the post-genomic era
Keywords: Glycopeptide antibiotics; Vancomycin; Teicoplanin; A40926; Dalbavancin; Natural product screening; Strain improvement; Fermentation; Genetic engineering; Combinatorial biochemistry; Dahp; 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase; Atf; acyltran
Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new
Keywords: Staphylococcus aureus; Tedizolid; Dalbavancin; Ceftaroline; Ceftobiprole; Oritavancin;
Evaluación de la evidencia clÃnica con dalbavancina
Keywords: Dalbavancina; Nuevos antibióticos; Gram positivos; Infecciones de la piel; Sepsis por catéter; Dalbavancin; New antibiotics; Gram-positive; Skin infections; Catheter-related sepsis;
Espectro antimicrobiano de dalbavancina. Mecanismo de acción y actividad in vitro frente a microorganismos Gram positivos
Keywords: Dalbavancina; Glucopéptidos; Lipoglucopéptidos; SARM; Microorganismos Gram positivos; multirresistentes; Enterococos resistentes a la vancomicina; Dalbavancin; Glycopeptides; Lipoglycopeptides; MRSA; Multiresistant Gram-positive; microorganisms; Vancomy
Dalbavancina: parámetros farmacocinéticos y farmacodinámicos
Keywords: Dalbavancina; Farmacocinética; Farmacocinético/farmacodinámico; Dalbavancin; Pharmacokinetics; Pharmacokinetics/pharmacodynamics;
Puntos de corte de dalbavancina y recomendaciones para el estudio de su actividad in vitro
Keywords: Dalbavancina; Lipoglucopéptidos; Punto de corte; Valor subrogado; Dalbavancin; Lipoglycopeptides; Breakpoints; Subrogate value;
Streptococcus suis serotype 9 strain GZ0565 contains a type VII secretion system putative substrate EsxA that contributes to bacterial virulence and a vanZ-like gene that confers resistance to teicoplanin and dalbavancin in Streptococcus agalactiae
Keywords: Streptococcus suis; Comparative genomics; Type VII secretion system; Teicoplanin; Dalbavancin;
A thorough QT study with dalbavancin: A novel lipoglycopeptide antibiotic for the treatment of acute bacterial skin and skin-structure infections
Keywords: QT; QTc prolongation; Thorough QT study; Dalbavancin; Anti-infective drug; Acute bacterial skin and skin-structure infection;
Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)
Keywords: Dalbavancin; SENTRY; Surveillance; Activity;
Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model
Keywords: Dalbavancin; Rifampicin; Staphylococcus aureus; Foreign-body infection
In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007–2009 study
Keywords: Dalbavancin; Telavancin; Vancomycin
A single-dose combination therapy that both prevents and treats anthrax infection
Keywords: AVA, anthrax vaccine adsorbed; Ab, antibody; ODN, oligodeoxynucleotide; Ag, antigen; PA, protective antigen; APC, antigen presenting cell; LD50, 50% lethal doseAnthrax; CpG ODN; Vaccine; Dalbavancin; Protection
Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007)
Keywords: DECIDE; Dalbavancin; Europe; Surveillance
New antibiotic agents for bloodstream infections
Keywords: Bloodstream infections; Daptomycin; Linezolid; Quinupristin/dalfopristin; Tigecycline; Dalbavancin; Telavancin; Oritavancin; Ceftobiprole; Doripenem; Colistin; Antibiotic lock therapy; Continuous intravenous antibiotic administration
Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactions
Keywords: Dalbavancin; Synergy; Lipoglycopeptide; Interaction studies
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)
Keywords: Dalbavancin; Lipoglycopeptide; Surveillance; Resistance; SSTI; CR-BSI
Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections
Keywords: Dalbavancin; Bacteremia; Catheters; Coagulase-negative staphylococci; PFGE; Molecular typing
Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes
Keywords: Viridans group streptococci; Antibiotic susceptibility testing; Dalbavancin; Daptomycin; Linezolid; Tigecycline
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens
Keywords: Dalbavancin; Gram-positive pathogens; Vancomycin resistance; Straphylococcus aureus; Streptococcus pneumoniae; Enterococcus; Coagulase-negative staphylococci;
Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo
Keywords: Dalbavancin; Vancomycin; Staphylococcus aureus; Device colonization;
Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres
Keywords: Dalbavancin; enterococci; Gram-positive cocci; Latin America; staphylococci; streptococci;